Constellation Pharmaceuticals Inc (CNST):企業の財務・戦略的SWOT分析

◆英語タイトル:Constellation Pharmaceuticals Inc (CNST) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH136570FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Constellation Pharmaceuticals Inc (CNST) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Constellation Pharmaceuticals Inc (Constellation) is a clinical biopharmaceutical company that focuses to develop novel therapeutics for the treatment of serious unmet medical needs in patients with cancers associated with abnormal gene expression. The company’s pipeline products include Pelabresib (CPI-0610) for the treatment of patients with myelofibrosis (MF); CPI-0209 for solid tumors and/or hematological malignancies; and CPI-482 for hematologic malignancies. It utilizes integrated epigenetics platform that enables it to validate targets and generate small molecules against the targets that modulate gene expression in tumor and immune cells. The company has operations in the US. Constellation is headquartered in Cambridge, Massachusetts, the US.

Constellation Pharmaceuticals Inc Key Recent Developments

Feb 24,2021: Constellation Pharmaceuticals announces fourth-quarter and full-year 2020 financial results
Oct 29,2020: Constellation Pharmaceuticals announces third-quarter 2020 financial results
Aug 05,2020: Constellation Pharmaceuticals announces second-quarter 2020 financial results, provides regulatory update
Jun 08,2020: Constellation Pharmaceuticals announces appointment of Dr. Jeffrey Humphrey as Chief Medical Officer
May 06,2020: Constellation Pharmaceuticals announces first-quarter 2020 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Constellation Pharmaceuticals Inc – Key Facts
Constellation Pharmaceuticals Inc – Key Employees
Constellation Pharmaceuticals Inc – Key Employee Biographies
Constellation Pharmaceuticals Inc – Major Products and Services
Constellation Pharmaceuticals Inc – History
Constellation Pharmaceuticals Inc – Company Statement
Constellation Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Constellation Pharmaceuticals Inc – Business Description
Constellation Pharmaceuticals Inc – Corporate Strategy
Constellation Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Constellation Pharmaceuticals Inc – Strengths
Constellation Pharmaceuticals Inc – Weaknesses
Constellation Pharmaceuticals Inc – Opportunities
Constellation Pharmaceuticals Inc – Threats
Constellation Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Constellation Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Constellation Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Constellation Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 24, 2021: Constellation Pharmaceuticals announces fourth-quarter and full-year 2020 financial results
Oct 29, 2020: Constellation Pharmaceuticals announces third-quarter 2020 financial results
Aug 05, 2020: Constellation Pharmaceuticals announces second-quarter 2020 financial results, provides regulatory update
Jun 08, 2020: Constellation Pharmaceuticals announces appointment of Dr. Jeffrey Humphrey as Chief Medical Officer
May 06, 2020: Constellation Pharmaceuticals announces first-quarter 2020 financial results
Apr 06, 2020: Constellation Pharmaceuticals announces appointment of Dr. Richard Levy to board of directors
Mar 10, 2020: Constellation Pharmaceuticals announces fourth-quarter and full-year 2019 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Constellation Pharmaceuticals Inc, Key Facts
Constellation Pharmaceuticals Inc, Key Employees
Constellation Pharmaceuticals Inc, Key Employee Biographies
Constellation Pharmaceuticals Inc, Major Products and Services
Constellation Pharmaceuticals Inc, History
Constellation Pharmaceuticals Inc, Subsidiaries
Constellation Pharmaceuticals Inc, Key Competitors
Constellation Pharmaceuticals Inc, Ratios based on current share price
Constellation Pharmaceuticals Inc, Annual Ratios
Constellation Pharmaceuticals Inc, Annual Ratios (Cont...1)
Constellation Pharmaceuticals Inc, Interim Ratios
Constellation Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Constellation Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Constellation Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Constellation Pharmaceuticals Inc (CNST):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Perficient Inc (PRFT):企業の財務・戦略的SWOT分析
    Perficient Inc (PRFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Genting Berhad:戦略・SWOT・企業財務分析
    Genting Berhad - Strategy, SWOT and Corporate Finance Report Summary Genting Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Hutchison 3G UK Limited:戦略・SWOT・企業財務分析
    Hutchison 3G UK Limited - Strategy, SWOT and Corporate Finance Report Summary Hutchison 3G UK Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Cinemark Holdings Inc (CNK):企業の財務・戦略的SWOT分析
    Cinemark Holdings Inc (CNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Oracle Corporation (ORCL):企業の財務・戦略的SWOT分析
    Oracle Corporation (ORCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • iCubate Inc:企業の製品パイプライン分析
    Summary iCubate Inc (iCubate) is a molecular diagnostic company that provides molecular diagnostic and in vitro diagnostic testing devices for syndromic testing. It develops cassettes and assays. The company’s pipeline products include flu typing cassette; HAI cassette; and STD cassette. iCubate uti …
  • Myovant Sciences Ltd (MYOV):製薬・医療:M&Aディール及び事業提携情報
    Summary Myovant Sciences Ltd (Myovant), a subsidiary of Roivant Sciences Ltd, is a biopharmaceutical company that develops and commercializes new treatments for women’s diseases and endocrine disorders. The company’s products include relugolix, an oral small molecule that functions as a gonadotropin …
  • Cemat AS (CEMAT):企業の財務・戦略的SWOT分析
    Cemat AS (CEMAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Oakdale Electric Cooperative:企業の戦略的SWOT分析
    Oakdale Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • ExxonMobil Pipeline Co:石油・ガス:M&Aディール及び事業提携情報
    Summary ExxonMobil Pipeline Co (EMPCO) a subsidiary of Exxon Mobil Corporation is an oil and gas company that offers petroleum products transportation solutions. The company transports crude oil, refined products, liquefied petroleum gases, natural gas liquids and chemical feed-stocks. Its distribut …
  • Fluxys SA:企業の戦略的SWOT分析
    Fluxys SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Berkley Renewables Inc (BKS):企業の財務・戦略的SWOT分析
    Berkley Renewables Inc (BKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Sangui BioTech International Inc (SGBI):企業の財務・戦略的SWOT分析
    Sangui BioTech International Inc (SGBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • The Advisory Board Company:企業の戦略的SWOT分析
    The Advisory Board Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • AES Gener SA (AESGENER):企業の財務・戦略的SWOT分析
    AES Gener SA (AESGENER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • CTS Corp (CTS):企業の財務・戦略的SWOT分析
    Summary CTS Corp (CTS) is a manufacturer of actuators, sensors and electronic components. The company offers products such as controls, pedals, piezoelectric sense products, sensors, switches, transducers, RFI filters, frequency control products, RF filters, specialty capacitors, specialty resistors …
  • KCC Corp (002380):企業の財務・戦略的SWOT分析
    KCC Corp (002380) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Odebrecht SA:企業の戦略的SWOT分析
    Odebrecht SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Lantheus Medical Imaging Inc-医療機器分野:企業M&A・提携分析
    Summary Lantheus Medical Imaging Inc (Lantheus Medical), a subsidiary of Lantheus Holdings, Inc., develops, manufactures, and commercializes diagnostic imaging agents and products for the diagnosis of conditions that affect heart, brain, lungs and other organs using echocardiography and nuclear imag …
  • China Gas Holdings Ltd (384):石油・ガス:M&Aディール及び事業提携情報
    Summary China Gas Holdings Ltd (CGHL) is a gas operator and service provider. The company offers piped natural gas, compressed natural gas, liquid petroleum gas and liquefied natural gas. Its activities include construction and operation of gas stations, gas pipeline infrastructure facilities, gas t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆